Pluristyx's iPSC platform provides therapeutic developers with a streamlined path from research to clinical application, offering high-quality, regulatory-compliant starting materials and advanced ...
In the world of biomedical innovation, few stories embody the spirit of perseverance, intuition, and collaboration quite like ...
Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...
MaxCyte will now host its earnings conference call on November 12, 2025 Management will present at the Stifel Healthcare Conference on November 11, 2025 and Stephens Investment Conference on November ...
Human progenitors are programmed into ependymal cells in brain organoids via GEMC1 and MCIDAS expression. This strategy ...
InMode Ltd. ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback